INHIBITORS OF VIRAL NUCLEIC ACID TRANSCRIPTASES*†

1971; Wiley; Volume: 33; Issue: 6 Series II Linguagem: Inglês

10.1111/j.2164-0947.1971.tb02625.x

ISSN

2164-0947

Autores

Shalom Z. Hirschman,

Tópico(s)

Bacterial Genetics and Biotechnology

Resumo

Transactions of the New York Academy of SciencesVolume 33, Issue 6 Series II p. 595-606 INHIBITORS OF VIRAL NUCLEIC ACID TRANSCRIPTASES*† Shalom Z. Hirschman, Shalom Z. Hirschman Division of Infectious Diseases Department of Medicine Mount Sinai School of Medicine of the City University of New York New York, N.Y. 10029.Search for more papers by this author Shalom Z. Hirschman, Shalom Z. Hirschman Division of Infectious Diseases Department of Medicine Mount Sinai School of Medicine of the City University of New York New York, N.Y. 10029.Search for more papers by this author First published: June 1971 https://doi.org/10.1111/j.2164-0947.1971.tb02625.xCitations: 18 † This paper was presented before a meeting of the Section of Microbiology on April 21, 1971. ‡ Supported in part by a grant from the New York Chemotherapy Foundation. AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Temin, H. M. 1963. The effects of actinomycin-D on growth of Rous sarcoma virus in vitro. Virology 20: 577. 2 Bader, J. P. 1965. Transformation by Rous sarcoma virus: a requirement for DNA synthesis. Science 149: 757. 3 Hirschman, S. Z., P. J. Fischinger, J. J. Zaccari & T. E. O'Connor. 1969. Effect of cytosine arabinoside on the replication of the Moloney sarcoma virus in 3T3 cell cultures. J. Natl. Cancer Inst. 42: 399. 4 Hirschman, S. Z., P. J. Fischinger & T. E. O'Connor. 1969. The inhibition by cytosine arabinoside of the replication of murine leukemia and sarcoma viruses in mouse embryo cultures. Int. J. Cancer 4: 671. 5 Temin, H. M. & S. Mizutani. 1970. RNA-dependent DNA polymerase in virions Rous sarcoma virus. Nature 226: 1211. 6 Baltimore, D. 1970. RNA-dependent DNA polymerase in virions of RNA tumor viruses. Nature 226: 1209. 7 Spiegelman, S., A. Burny, M. R. Das, J. Keydar, J. Schlom, M. Travnicek & K. Watson. 1970. DNA-directed DNA polymerase activity in oncogenic RNA viruses. Nature 227: 1029. 8 Mizutani, S., D. Boettiger & H. M. Temin. 1970. A DNA-dependent DNA polymerase and a DNA endonuclease in virions of Rous sarcoma virus. Nature 228: 424. 9 Schlom, J., D. H. Harter, A. Burny & S. Spiegelman. 1971. DNA polymerase activities in virions of visna virus, a causative agent of a “slow” neurological disease. Proc. U.S. Nat. Acad. Sci. 68: 182. 10 Scolnick, E. M., S. A. Aaronson, G. J. Todaro & W. P. Parks. 1971. RNA dependent DNA polymerase activity in mammalian cells. Nature 229: 318. 11 Gallo, R. C., S. S. Yang & R. C. Ting. 1970. RNA dependent DNA polymerase of human acute leukemic cells. Nature 228: 927. 12 Kiessling, A. A., G. H. Weber, A. O. Deeney, E. A. Possehl & G. S. Beaudreau. 1971. Deoxyribonucleic acid polymerase activity associated with a plasma particulate fraction from patients with chronic lymphocytic leukemia. J. Virol. 7: 221. 13 Baltimore, D., A. S. Huang & M. Stampfer. 1970. Ribonucleic acid synthesis of vesicular stomatitis virus. II. An RNA polymerase in the viron. Proc. U.S. Nat. Acad. Sci. 66: 572. 14 Huang, A. S., D. Baltimore, & M. A. Bratt. 1971. Ribonucleic acid polymerase in virions of Newcastle disease virus: comparison with vesicular stomatitis virus polymerase. J. Virol. 7: 389. 15 Gurgo, C., R. K. Ray, L. Thiry & M. Green. 1971. Inhibitors of the RNA and DNA dependent polymerase activities of RNA tumor viruses. Nature New Biol. 229: 111. 16 Waring, M. 1970. Variation of the supercoils in closed circular DNA by binding of antibiotics and drugs: evidence for molecular models involving intercalation. J. Molec. Biol. 54: 247. 17 Lowry, O. H., N. J. Rosbrough, L. A. Farr & R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265. 18 Vargues, R., H. Vargues & S. Vernace. Automated immunodiffusion test for Australia antigen. Technicon Internat. Symp. In press. 19 Vernace, S., R. Vargues, F. Paronetto & F. Schaffner. Automated complement fixation test for Australia antigen. Technicon Internat. Symp. In press. 20 Vall-Spinosa, A., W. Lester, T. Moulding, P. T. Davidson & J. K. McClatchy. 1970. Rifampin in the treatment of drug-resistant Mycobacterium tuberculosis infections. New Eng. J. Med. 283: 616. 21 Deal, W. B. & E. Sanders. 1969. Efficacy of rifampin in treatment of meningococcal carriers. New Eng. J. Med. 281: 641. 22 Sippel, A. & G. Hartmann. 1968. Mode of action of rifampicin in the RNA polymerase reaction. Biochim. Biophys. Acta. 157: 218. 23 Subak-Sharpe, H. H., M. C. Timbury & J. F. Williams. 1969. Rifampicin inhibits the growth of some mammalian viruses. Nature 222: 341. 24 Diggelmann, H. & C. Weismann. 1969. Rifampicin inhibits focus formation in chick fibroblasts infected with Rous sarcoma virus. Nature 224: 1277. 25 Nagayama, A., B. G. T. Pogo & S. Dales. 1970. Biogenesis of vaccinia: Separation of early stages from maturation by means of rifampicin. Virology 40: 1039. 26 Hirschman, S. Z., S. J. Vernace & F. Schaffner. 1971. DNA polymerase in preparations containing Australian antigen. Lancet 1: 1099. 27 Friend, C. Unpublished data. 28 Friend, C., M. C. Patuleia & E. de Harven. 1966. Erythrocytic maturation in vitro of murine (Friend) virus-induced leukemic cells. Nat. Cancer Inst. Monogr. 22: 505. 29 Lerman, L. S. 1961. Structural considerations in the interaction of DNA and acridines. J. Molec. Biol. 3: 18. 30 Waring, M. 1965. Complex formation between ethidium bromide and nucleic acids. J. Molec. Biol. 13: 269. 31 Saffhill, R., H. Schneider-Bernloeh, L. E. Orgel & S. Spiegelman. 1970. In vitro selection of bacteriophage Qß ribonucleic acid variants resistant to Ethidium bromide. J. Molec. Biol. 51: 531. 32 Spiegelman, S., A. Burny, M. R. Das, J. Keydar, J. Schlom, M. Travnicek & K. Watson. 1970. Synthetic DNA-RNA hybrids and RNA-RNA duplexes as templates for the polymerases of the oncogenic RNA viruses. Nature 228: 430. 33 Tao, T., J. H. Nelson & C. R. Cantor. 1970. Conformational studies on transfer ribonucleic acid. Fluorescence lifetime and nanosecond depolarization measurements on bound ethidium bromide. Biochem. 9: 3514. 34 Blumberg, B. S., H. J. Alter & S. Visnich. 1965. A “new” antigen in leukemia sera. J.A.M.A. 191: 541. 35 Blumberg, B. S., A. I. Sutnick & W. T. London. 1970. Australia antigen as a hepatitis virus. Amer. J. Med. 48: 1. 36 Bayer, M. E., B. S. Blumberg & B. Werner. 1968. Particles associated with Australia antigen in the sera of patients with leukemia, Down's syndrome and hepatitis. Nature 218: 1057. 37 Millman, I., V. Zavatone, B. J. S. Gerstley & B. S. Blumberg. 1969. Australia antigen in the nuclei of liver cells of patients with viral hepatitis detected by the fluorescent antibody technique. Nature 222: 181. 38 Jozwiak, W., J. Koscielak, K. Madalinski, W. J. Borzosko, A. Nowoslawski & M. Kloczewiak. 1971. RNA of Australia antigen. Nature New Biol. 229: 92. 39 Gerin, J. L., R. H. Purcell, M. D. Hoggan, P. V. Holland & R. M. Chanock. 1969. Biophysical properties of Australia antigen. J. Virol. 4: 763. 40 Hirschman, S. Z. 1971. Reflections on latent viruses; a new definition of an infectious agent. Mt. Sinai J. Med. 38: 257. 41 Kandaswamy, T. S. & J. F. Henderson. 1962. Intracellular differentiation of purine ribonucleotides derived from endogenous and exogenous sources. Biochim. Biophys. Acta. 61: 86. Citing Literature Volume33, Issue6 Series IIJune 1971Pages 595-606 ReferencesRelatedInformation

Referência(s)